Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
6.98
+0.32 (4.80%)
At close: Mar 6, 2026, 4:00 PM EST
6.98
0.00 (0.00%)
After-hours: Mar 6, 2026, 4:04 PM EST
Aligos Therapeutics Employees
Aligos Therapeutics had 70 employees as of December 31, 2024. The number of employees increased by 4 or 6.06% compared to the previous year.
Employees
70
Change (1Y)
4
Growth (1Y)
6.06%
Revenue / Employee
$31,229
Profits / Employee
-$345,614
Market Cap
42.95M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Xilio Therapeutics | 64 |
| Palatin Technologies | 29 |
| Jasper Therapeutics | 27 |
| Veru Inc. | 20 |
| Atossa Therapeutics | 15 |
| Sensei Biotherapeutics | 15 |
| NovaBay Pharmaceuticals | 14 |
| Apollomics | 13 |
ALGS News
- 1 day ago - Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 8 days ago - Aligos Therapeutics to Announce 4th Quarter 2025 Financial Results on March 5, 2026 - GlobeNewsWire
- 11 days ago - Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI) - GlobeNewsWire
- 5 weeks ago - Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates - GlobeNewsWire
- 3 months ago - Aligos Therapeutics Presents Positive Data at HEP-DART 2025 - GlobeNewsWire
- 3 months ago - Aligos Therapeutics, Inc. (ALGS) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 months ago - Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025 - GlobeNewsWire